A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer. [electronic resource]
Producer: 20040517Description: 171-4; discussion 174-5 p. digitalISSN:- 0302-2838
- Androgen Antagonists -- therapeutic use
- Cancer Vaccines -- administration & dosage
- Diphtheria Toxoid -- chemistry
- Disease Progression
- Dose-Response Relationship, Drug
- Gonadotropin-Releasing Hormone -- chemistry
- Humans
- Male
- Oligopeptides -- chemistry
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Testosterone -- blood
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.